000			03175cam a22003618i 4500
001			17544795
003			EG-NcFUE
005			20230824160759.0
008			121128s2013 stk b 001 0 eng
020			_a9780702042904
020			_a9780702042911 (International)
035			_a(DNLM)101596715
040			_aDNLM/DLC _cDLC _erda
082	0	0	_a615.19 _223 _bA.
245	0	0	_aAulton's pharmaceutics : _bthe design and manufacture of medicines / _cedited by Michael E. Aulton and Kevin M.G. Taylor.
246	1		_aPharmaceutics
250			_a4th edtion
264		1	_aEdinburgh : _bChurchill Livingstone/Elsevier, _c2013
300			_axiii, 894 pages : _billustrations ; _c25 cm
336			_atext _2rdacontent
337			_aunmediated _2rdamedia
338			_avolume _2rdacarrier
500			_apharmacy bookfair2015
504			_aIncludes bibliographical references and index.
505	0		_a1. Design of dosage forms. PART 1: Scientific principles of dosage form design. 2. Dissolution and solubility. 3. Properties of solutions. 4. Surfaces and interfaces. 5. Disperse systems. 6. Rheology. 7. Kinetics. PART 2: Particle science and powder technology. 8. Solid-state properties. 9. Particle size analysis. 10. Particle size reduction and size separation. 11. Mixing. 12. Powder flow. PART 3: Pharmaceutical microbiology and sterilization. 13. Fundamentals of microbiology. 14. Pharmaceutical applications of microbiological techniques. 15. Action of physical and chemical agents on microorganisms. 16. Principles of sterilization. 17. Sterilization in practice. PART 4: Biopharmaceutical principles of drug delivery. 18. Introduction to biopharmaceutics. 19. Gastrointestinal tract - physiology and drug absorption. 20. Bioavailability - physicochemical and dosage form factors. 21. Assessment of biopharmaceutical properties. 22. Dosage regimens. PART 5: Dosage form design and manufacture. 23. Pharmaceutical preformulation. 24. Solutions. 25. Clarification. 26. Suspensions . 27. Emulsions and Creams. 28. Powders, granules and granulation. 29. Drying. 30. Tablets and compaction. 31. Modified-release oral drug delivery. 32. Coating of tablets and multiparticulates. 33. Hard capsules. 34. Soft capsules. 35 Dissolution testing of solid dosage forms. 36 Parenteral drug delivery. 37. Pulmonary drug delivery. 38. Nasal drug delivery. 39. Topical and transdermal drug delivery. 40. Wound dressings. 41. Ocular drug delivery. 42. Rectal and vaginal drug delivery. 43. Design and administration of medicines for children and the elderly. 44. The formulation and manufacture of plant medicines. 45. Pharmaceutical nanotechnology and nanomedicines. 46. Delivery of biopharmaceuticals. Part 6: PACKAGING AND STABILITY OF PHARMACEUTICAL PRODUCTS. 47. Packaging. 48. Chemical stability in dosage forms. 49. Product stability and stability testing. 50. Microbial contamination, spoilage and preservation of medicines.
650	1	2	_aDosage Forms.
650	2	2	_aBiopharmaceutics _xmethods.
650	2	2	_aDrug Compounding _xmethods.
650	2	2	_aDrug Design.
700	1		_aAulton, Michael E. _eeditor
700	1		_aTaylor, Kevin, _d1961-, _eeditor
942			_2ddc _cBK
999			_c9400 _d9400